See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
DHTV
Popular
Top Rated

Related Medications Videos on Diabetes Health TV

ReliOn at Wal-Mart

Bob Guest

ReliOn at Wal-Mart

Nipro Diabetes Systems Introduces The Amigo®

Tony Delamaza

Nipro Diabetes Systems Introduces The Amigo®

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

Apidra Archives

Apidra

Updated 15 weeks ago
 
New Type 2 Drugs Change Treatment Decisions

Metformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of that population in 1997 to 53 percent in 2012. But that increase has since plateaued due to the introduction of additional drugs that target insulin secretion and glucose regulation.

Comments 0 comments - Jan 4, 2014 - * * * * *

My Pump Almost Killed Me... Twice

One of the greatest technological advancements in diabetes care has been the insulin pump.  For one, it gives you the illusion of being "normal" because you no longer have to inject insulin throughout the day. Instead, you "bolus" by pushing a button on the pump itself or using a remote control. It allows better glucose management because you can adjust your basal rate (the "background" insulin dose) by increments of one thousandth of a unit every hour.  Especially when you're moving from the peaks and valleys of NPH or the restraints and hazards of Lantus, the freedom of living with an insulin pump is incredible.  But pumps do not come without their kinks.

Comments 16 comments - Jul 31, 2012 - * * * * *

Pain and Joy

As I explained in my previous articles, I was pre-eclamptic and was admitted to the hospital at 37 weeks. I had a migraine that lasted for ten hours after I entered the emergency room. I had experienced migraines before and knew that Tylenol wouldn't ease the pain, so I went untreated even in the hospital. About twelve hours after admission, I was brought to the women's floor, where I waited for my already injected Levemir supply to diminish in my bloodstream.

Comments 1 comment - Jan 2, 2012 - * * * * *

The Second Trimester- Pregnant with Type 1 Diabetes

Welcome to the second trimester!  By now, many type 1s are experiencing fewer hypoglycemic episodes, and insulin resistance is just beginning to rear its head.  You're on the other side of the miscarriage worry hump and getting settled into the pregnancy routine.  Congratulations!  Take a few minutes each day to celebrate your successes and pat your stomach with a smile, knowing you are doing the best you can to give your growing child everything she needs.  

Comments 2 comments - Oct 26, 2011 - * * * * *

Apidra SoloSTAR Pen Now Available in the United States

Insulin pens have been very popular in Europe for quite some time and interest is building steadily in the United States. Many people prefer an insulin pen over the standard syringe and vial because the pens are more convenient and more accurate.  Pre-filled disposable insulin pens are the easiest of all, because you don't never have to install a new cartridge when the pen is empty-you just toss it out.

Comments 4 comments - Apr 28, 2009 - * * * * *

FDA Approves Apidra for Use With Children
FDA Approves Apidra for Use With Children

The FDA has approved the fast-acting insulin Apidra (insulin glulisine) for use in children four years and older who have type 1 diabetes. 

Comments 1 comment - Nov 3, 2008 - * * * * *

Sanofi-Aventis Study Sees Significant A1c Reductions with Lantus and Apidra Compared to Pre-mixed Insulin for Type 2s

At the recent 44th annual meeting of the European Association for the Study of Diabetes (EASD), sanofi-aventis announced a study demonstrating that a basal-bolus insulin regimen with Lantus® once daily (basal insulin) and rapid-acting Apidra® (insulin glulisine [rDNA origin] injection) at mealtime (bolus insulin) resulted in significant A1c reductions from baseline as compared to pre-mixed insulin in people with type 2 diabetes.

Comments 5 comments - Sep 29, 2008 - * * * *

 
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.